Literature DB >> 16686474

Icariin: a special antioxidant to protect linoleic acid against free-radical-induced peroxidation in micelles.

Zai-Qun Liu1.   

Abstract

The objective in this work is to determine the antioxidant capacity and effectiveness of icariin (2-(4'-methoxylphenyl)-3-rhamnosido-5-hydroxyl-7-glucosido-8-(3'-methyl-2-butylenyl)-4-chromanone), the major component in herba epimedii being used widely in traditional Chinese medicine for the treatment of artherosclerosis and neuropathy, in which 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH)-induced peroxidation of linoleic acid (LH) in sodium dodecyl sulfate (SDS) acts as the experimental system. By containing an intramolecular hydrogen bond, icariin protects LH against AAPH-induced peroxidation of LH only in SDS, an anionic micelle. The number of trapping peroxyl radicals (LOO(*)), n, by icariin is just 0.0167 whereas alpha-tocopherol (TOH) and L-ascorbyl-6-laurate (VC-12) are 2.14 and 1.25, respectively, with reference to the n of 6-hydroxyl-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), 2.00. This is also related to how the intramolecular hydrogen bond enhances the bond dissociation enthalpy (BDE) of O-H in icariin. However, calculation of the inhibition rate constant, k(inh), a kinetic parameter to describe the reaction between the antioxidant and LOO(*), results in a k(inh) of icariin at about one magnitude larger than those of Trolox, TOH, and VC-12. This fact reveals that, by the view of kinetics, icariin is an antioxidant with much higher effectiveness. In addition, the antioxidant capacities of icariin used together with other antioxidants have been determined and the results indicate that the n of icariin decreases markedly while the n values of Trolox and TOH increase, even if the n of icariin is a negative value in the presence of VC-12. Furthermore, an analysis of k(inh) in this case reveals that the k(inh)(icariin) increases nearly one magnitude with the decrease of k(inh)(Trolox) and no remarkable change occurs for k(inh)(TOH). The negative value of k(inh)(icariin) in the presence of VC-12 can be regarded as the icariin functions as a prooxidant that can be rectified by VC-12 effectively. These findings implicate that the evaluation of antioxidant activity should not only focus on an n value, a thermodynamic possibility, but k(inh) and the charge property of the micelle should be also taken into account. To some extent, the latter factors are more important than the thermodynamic possibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686474     DOI: 10.1021/jp053998z

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.781


  5 in total

1.  Preparation and biological evaluation of chitosan-collagen-icariin composite scaffolds for neuronal regeneration.

Authors:  Chun Rong Yang; Jing Di Chen
Journal:  Neurol Sci       Date:  2012-07-26       Impact factor: 3.307

2.  Icariin attenuates hypoxia-induced oxidative stress and apoptosis in osteoblasts and preserves their osteogenic differentiation potential in vitro.

Authors:  H-P Ma; X-N Ma; B-F Ge; P Zhen; J Zhou; Y-H Gao; C J Xian; K-M Chen
Journal:  Cell Prolif       Date:  2014-10-30       Impact factor: 6.831

3.  Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats.

Authors:  Lin Wang; Yongde Xu; Huixi Li; Hongen Lei; Ruili Guan; Zhezhu Gao; Zhongcheng Xin
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

4.  Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction.

Authors:  Xiyou Wang; Chuanhai Liu; Yong Xu; Ping Chen; Yue Shen; Yansheng Xu; Yubo Zhao; Weihao Chen; Xinyu Zhang; Yun Ouyang; Yi Wang; Changliang Xie; Maojun Zhou; Cuilong Liu
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

Review 5.  Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?

Authors:  Cong Chen; Lin-Tong Yu; Bai-Ru Cheng; Jiang-Lin Xu; Yun Cai; Jia-Lin Jin; Ru-Li Feng; Long Xie; Xin-Yan Qu; Dong Li; Jing Liu; Yan Li; Xiao-Yun Cui; Jin-Jin Lu; Kun Zhou; Qian Lin; Jie Wan
Journal:  Front Cardiovasc Med       Date:  2022-02-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.